Cargando…

非小细胞肺癌EGFR基因靶向治疗研究进展

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have brought great clinical benefit to patients with EGFR-sensitive mutations. With the deepening of clinical and basic research, EGFR-TKIs have received more and more attention. In this review, we summarize the latest research...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973286/
https://www.ncbi.nlm.nih.gov/pubmed/28103975
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.09
_version_ 1783326584120279040
collection PubMed
description Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have brought great clinical benefit to patients with EGFR-sensitive mutations. With the deepening of clinical and basic research, EGFR-TKIs have received more and more attention. In this review, we summarize the latest research development about EGFR-targeted drugs in 2016.
format Online
Article
Text
id pubmed-5973286
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59732862018-07-06 非小细胞肺癌EGFR基因靶向治疗研究进展 Zhongguo Fei Ai Za Zhi 综述 Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have brought great clinical benefit to patients with EGFR-sensitive mutations. With the deepening of clinical and basic research, EGFR-TKIs have received more and more attention. In this review, we summarize the latest research development about EGFR-targeted drugs in 2016. 中国肺癌杂志编辑部 2017-01-20 /pmc/articles/PMC5973286/ /pubmed/28103975 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.09 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
非小细胞肺癌EGFR基因靶向治疗研究进展
title 非小细胞肺癌EGFR基因靶向治疗研究进展
title_full 非小细胞肺癌EGFR基因靶向治疗研究进展
title_fullStr 非小细胞肺癌EGFR基因靶向治疗研究进展
title_full_unstemmed 非小细胞肺癌EGFR基因靶向治疗研究进展
title_short 非小细胞肺癌EGFR基因靶向治疗研究进展
title_sort 非小细胞肺癌egfr基因靶向治疗研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973286/
https://www.ncbi.nlm.nih.gov/pubmed/28103975
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.09
work_keys_str_mv AT fēixiǎoxìbāofèiáiegfrjīyīnbǎxiàngzhìliáoyánjiūjìnzhǎn
AT fēixiǎoxìbāofèiáiegfrjīyīnbǎxiàngzhìliáoyánjiūjìnzhǎn